Highlights GeneOne Life Science, Inc.

Equities

A011000

KR7011000007

End-of-day quote Korea S.E. Other stock markets 18:00:00 2024-06-04 EDT			5-day change	1st Jan Change
2,270 ^KRW	0.00%		+0.44%	-20.07%

05-16	GeneOne Life Science, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
03-28	GeneOne Life Science, Inc. announced that it has received KRW 3.6000014 billion in funding	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

GeneOne Life Science, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-16	CI
GeneOne Life Science, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	03-27	CI
GeneOne Life Science, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-14	CI
GeneOne Life Science, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14	CI
GeneOne Life Science, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
GeneOne Life Science, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14	CI
GeneOne Life Science, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-16	CI
GeneOne Life Science, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-16	CI
GeneOne Life Science, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-08	CI
VGX Pharmaceuticals, Inc. Terminates CELLECTRA Device License Agreement with GeneOne	20-10-15	CI
INOVIO and GeneOne Life Science Report Positive Phase 1/2a Clinical Data with DNA Vaccine INO-4700 for MERS Coronavirus a the American Society of Gene & Cell Therapy Conference	20-04-28	CI
Inovio and Korean Partner Dose 1st Subject In Trial to Develop Vaccine to Prevent Hepatitis C Infection	18-09-04	CI
GeneOne Life Science Inc. Announces Full Enrollment of First-In-Human Study of MERS Vaccine	16-08-08	CI
Inovio Pharmaceuticals and GeneOne Life Science Receive Approval for First-in-Man Zika Vaccine Clinical Trial	16-06-20	CI
Inovio Pharmaceuticals and GeneOne Life Science Initiate Patient Recruitment for MERS Vaccine Trial	16-01-28	CI
GeneOne Life Science Announces Initiation of Collaborative Research Program with Inovio Pharmaceuticals	16-01-22	CI
GeneOne Life Science Inc. and Inovio Pharmaceuticals, Inc. Receive Clearance from U.S. Food and Drug Administration for First-in-Human Clinical Study of its Collaborative Vaccine for MERS	15-11-19	CI
GeneOne Life Science Inc. and the Walter Reed Army Institute of Research Partner to Develop MERS Vaccine	15-11-10	CI
Inovio Pharmaceuticals, Inc. Partners with Geneone Life Science Inc. for MERS Immunotherapy Clinical Development	15-05-27	CI
Inovio Pharmaceuticals, Inc. Announces Phase I Clinical Trial for Ebola in Collaboration with GeneOne Life Science Inc	14-09-24	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights GeneOne Life Science, Inc.

Equities

A011000

KR7011000007

Highlights

Filters